Validation of an RLIP76 Assay in Humans



Status:Active, not recruiting
Conditions:Endocrine, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:December 2012

Use our guide to learn which trials are right for you!

Validation of RLIP76 Assay and Exploratory Study of RLIP76 Correlation Among Patients With Type 2 Diabetes and Metabolic Syndrome

The current proposal extends work done in mouse models evaluating the consistency of
measuring RLIP76 in a clinical cohort (Aim 1) by using guidelines provided by the NIH for
validating biomarkers. We will also proceed to estimate the effect size of a potential
correlation of RLIP76 with standard MsY treatment measures such as hgbA1c, LDL, and
triglyceride levels in a longitudinal prospective study ( Aim 2) that will follow a cohort
of patients with MsY who seek care at the City of Hope Endocrine clinic over a 12 month
period..


Inclusion Criteria:

- Registered patient of City of Hope and followed in the Endocrine Clinic. Must have
documentation of a diagnosis of diabetes identified by the problem list in the
patient's electronic health record.

- Must demonstrate features of MsY by possessing any of the following characteristics
and/or receiving treatment for diabetes, hyperlipidemia, and/or hypertriglyceridemia.

- Central obesity: waist circumference ≥ 102 cm or 40 inches (male), ≥ 88 cm or 36
inches (female)

- Dyslipidemia: TG ≥ 1.7 mmol/L (150 mg/dl)

- Dyslipidemia: HDL-C < 40 mg/dL (male), < 50 mg/dL (female)

- Blood pressure ≥ 130/85 mmHg

- Fasting plasma glucose ≥ 6.1 mmol/L (110 mg/dl)
We found this trial at
1
site
Duarte, California 91010
?
mi
from
Duarte, CA
Click here to add this to my saved trials